Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.49 |
| ▸ | PRKCA | P17252 | 3/20 | 0.49 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.49 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17539124 | 1.00 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL19608786 | 0.91 | PTGS2 (0.57) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL4728781 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL4728775 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL11314352 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL4732320 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL4730460 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL27528077 | 0.83 | TSHR (0.71) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL22470008 | 0.83 | PRKCA (0.46) | ALDH1A1LMNATSHRPTGS2TP53 | |
| SCHEMBL17498842 | 0.82 | PTGS2 (0.59) | ALDH1A1LMNATSHRPTGS2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102373-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2026-04-16 | — | — | US | disclosed |
| US-20250352510-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2025-11-20 | — | — | US | disclosed |
| US-20250213522-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2025-07-03 | — | — | US | disclosed |
| EP-4578865-A2 | LYMPH DIRECTING PRODRUGS | Monash University (AU) | 2025-07-02 | — | — | EP | disclosed |
| EP-3180349-B1 | LYMPH DIRECTING PRODRUGS AND THERAPEUTIC USES THEREOF | UNIV MONASH (AU) | 2025-03-12 | — | — | EP | disclosed |
| US-20220211664-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2022-07-07 | — | — | US | disclosed |
| US-11311512-B2 | Lymph directing prodrugs | MONASH UNIVERSITY (AU) | 2022-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220211664-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | ALDH1A1 1056/4885LMNA 3766/4885TSHR 3045/4885 |
| US-11311512-B2 | Lymph directing prodrugs | LTA, ABCB11, LYN | ALDH1A1 1056/4885LMNA 3766/4885TSHR 3045/4885 |
| US-20260102373-A1 | LYMPH DIRECTING PRODRUGS | MALT1, CES1, LIPA | ALDH1A1 1086/4885LMNA 964/4885TSHR 1545/4885 |
| US-20250213522-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | ALDH1A1 1056/4885LMNA 3766/4885TSHR 3045/4885 |
| US-20250352510-A1 | LYMPH DIRECTING PRODRUGS | LTA, ABCB11, LYN | ALDH1A1 1056/4885LMNA 3766/4885TSHR 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.